{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T18:09:19Z","timestamp":1788977359984,"version":"build-2803163510"},"reference-count":22,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"\n Aim of the study<\/jats:title>\n Intraductal papillary mucinous neoplasms (IPMNs) are among the most common cystic pancreatic neoplasms, with a potential to progress to malignancy. The increasing prevalence of IPMNs, coupled with the widespread use of GLP-1 receptor agonists (GLP-1 RAs) for diabetes and obesity management, raises concerns about the safety of these medications in patients with preexisting pancreatic conditions. Despite their proven metabolic benefits, questions remain about their impact on pancreatic pathology. This study investigates the association between GLP-1 RA use and IPMN progression to address this critical gap in the current literature.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n This retrospective multicentric cohort study will analyse data from January 2010 to July 2026 across three Swiss tertiary institutions. Patients with a radiological diagnosis of IPMN and\/or treated with GLP-1 RAs will be included. Patients will be stratified into four groups according to a 2\u2009\u00d7\u20092 design based on GLP-1 RAs exposure and IPMN status. The primary objective is to evaluate the impact of GLP-1 RAs on IPMN progression using radiological criteria from the Kyoto 2023 Consensus. Secondary objectives include assessing changes in tumour markers (CA19\u22129, CEA), the incidence of acute pancreatitis, the progression of IPMNs to high-grade dysplasia or invasive carcinoma, and the need for surgical intervention or altered surveillance protocols associated with GLP1 RAs use.<\/jats:p>\n <\/jats:sec>\n \n Discussion<\/jats:title>\n This study aims to explore potential associations between GLP-1 RA use and changes in IPMN characteristics, tumour markers, and disease progression. Given the retrospective design and expected small sample size (estimated at 30\u201360 patients in total), the study may not be powered to establish definitive correlations. Nonetheless, it will generate preliminary data to help inform hypotheses and guide future research. Any observed trends could provide valuable insights into the safety of GLP-1 RAs in patients with IPMNs and contribute to more informed clinical decision-making regarding the use of these agents in a population at risk for pancreatic disease progression.<\/jats:p>\n <\/jats:sec>\n \n Trial registration<\/jats:title>\n \n ClinicalTrials.gov\n NCT07014709<\/jats:ext-link>\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1371\/journal.pone.0357577","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:38:11Z","timestamp":1788975491000},"page":"e0357577","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of GLP-1 receptor agonists on patients with intraductal papillary mucinous neoplasms: Study protocol for a multicentric cohort study"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7705-295X","authenticated-orcid":true,"given":"Melissa","family":"Lagger","sequence":"first","affiliation":[{"name":"Fribourg Cantonal Hospital","place":["Villars-sur-Gl\u00e2ne, Switzerland"],"department":["Department of Surgery"]},{"name":"Faculty of Science and Medicine, University of Fribourg","place":["Fribourg, Switzerland"],"department":["Department of Medical and Surgical Specialties"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Najberg","sequence":"additional","affiliation":[{"name":"Direction of IT service Education and Research, University of Fribourg","place":["Fribourg, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almir","family":"Miftaroski","sequence":"additional","affiliation":[{"name":"Fribourg Cantonal Hospital","place":["Villars-sur-Gl\u00e2ne, Switzerland"],"department":["Department of Surgery"]},{"name":"Faculty of Science and Medicine, University of Fribourg","place":["Fribourg, Switzerland"],"department":["Department of Medical and Surgical Specialties"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3630-8897","authenticated-orcid":true,"given":"Lucien","family":"Widmer","sequence":"additional","affiliation":[{"name":"Faculty of Science and Medicine, University of Fribourg","place":["Fribourg, Switzerland"],"department":["Department of Medical and Surgical Specialties"]},{"name":"Fribourg Cantonal Hospital","place":["Villars-sur-Gl\u00e2ne, Switzerland"],"department":["Department of Radiology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Di Renzo","sequence":"additional","affiliation":[{"name":"Fribourg Cantonal Hospital","place":["Villars-sur-Gl\u00e2ne, Switzerland"],"department":["Department of Radiology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6963-1164","authenticated-orcid":true,"given":"Pouya","family":"Iranmanesh","sequence":"additional","affiliation":[{"name":"Hirslanden Clinics Geneva","place":["Geneva, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Matter","sequence":"additional","affiliation":[{"name":"Universit\u00e4tsklinik f\u00fcr Viszerale Chirurgie und Medizin, Universit\u00e4t Bern, Inselspital","place":["Bern, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boran","family":"Tekdogan","sequence":"additional","affiliation":[{"name":"University Hospitals of Geneva","place":["Gen\u00e8ve, Switzerland"],"department":["Division of Digestive Surgery"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2767-3219","authenticated-orcid":true,"given":"St\u00e9phanie","family":"Perrodin","sequence":"additional","affiliation":[{"name":"Universit\u00e4tsklinik f\u00fcr Viszerale Chirurgie und Medizin, Universit\u00e4t Bern, Inselspital","place":["Bern, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beat","family":"Gloor","sequence":"additional","affiliation":[{"name":"Universit\u00e4tsklinik f\u00fcr Viszerale Chirurgie und Medizin, Universit\u00e4t Bern, Inselspital","place":["Bern, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Toso","sequence":"additional","affiliation":[{"name":"University Hospitals of Geneva","place":["Gen\u00e8ve, Switzerland"],"department":["Division of Digestive Surgery"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Frossard","sequence":"additional","affiliation":[{"name":"Hirslanden Clinics Geneva","place":["Geneva, Switzerland"]},{"name":"University Hospitals of Geneva","place":["Gen\u00e8ve, Switzerland"],"department":["Division of Gastroenterology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5464-6953","authenticated-orcid":true,"given":"Michel","family":"Adamina","sequence":"additional","affiliation":[{"name":"Universit\u00e4tsklinik f\u00fcr Viszerale Chirurgie und Medizin, Universit\u00e4t Bern, Inselspital","place":["Bern, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"Buhler","sequence":"additional","affiliation":[{"name":"Fribourg Cantonal Hospital","place":["Villars-sur-Gl\u00e2ne, Switzerland"],"department":["Department of Surgery"]},{"name":"Faculty of Science and Medicine, University of Fribourg","place":["Fribourg, Switzerland"],"department":["Department of Medical and Surgical Specialties"]},{"name":"Hirslanden Clinics Geneva","place":["Geneva, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"issue":"2","key":"pone.0357577.ref001","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pan.2023.12.009","article-title":"International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas","volume":"24","author":"T Ohtsuka","year":"2024","journal-title":"Pancreatology"},{"issue":"5","key":"pone.0357577.ref002","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.pan.2017.07.007","article-title":"Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas","volume":"17","author":"M Tanaka","year":"2017","journal-title":"Pancreatology"},{"issue":"5","key":"pone.0357577.ref003","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/01.sla.0000124386.54496.15","article-title":"Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection","volume":"239","author":"R Salvia","year":"2004","journal-title":"Ann Surg"},{"issue":"5","key":"pone.0357577.ref004","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cgh.2011.12.029","article-title":"The clinical relevance of the increasing incidence of intraductal papillary mucinous neoplasm","volume":"10","author":"DA Klibansky","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"pone.0357577.ref005","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/ajg.2013.42","article-title":"Italian Association for Study of Pancreas (AISP); Intraductal Papillary Mucinous Neoplasm (IPMN) Study Group. Risk factors for intraductal papillary mucinous neoplasm (IPMN) of the pancreas: a multicentre case-control study","volume":"108","author":"G Capurso","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"pone.0357577.ref006","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1080\/00365521.2017.1318948","article-title":"Intraductal papillary mucinous neoplasm of the pancreas - epidemiology, risk factors, diagnosis, and management","volume":"52","author":"L Aronsson","year":"2017","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"pone.0357577.ref007","first-page":"124","article-title":"Acute pancreatitis due to different semaglutide regimens: an updated meta-analysis","volume":"71","author":"W Masson","year":"2024","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)"},{"issue":"2","key":"pone.0357577.ref008","doi-asserted-by":"crossref","first-page":"65","DOI":"10.15605\/jafes.037.02.14","article-title":"Efficacy and safety of semaglutide for weight loss in obesity without diabetes: a systematic review and meta-analysis","volume":"37","author":"HC Tan","year":"2022","journal-title":"J ASEAN Fed Endocr Soc"},{"issue":"8","key":"pone.0357577.ref009","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1111\/dom.16489","article-title":"GLP-1 receptor agonists and the risk for cancer: a meta-analysis of randomized controlled trials","volume":"27","author":"GA Silverii","year":"2025","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"pone.0357577.ref010","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1038\/s41598-019-38956-2","article-title":"Glucagon-like peptide-1 receptor agonists and pancreatic cancer: a meta-analysis with trial sequential analysis","volume":"9","author":"LC Pinto","year":"2019","journal-title":"Sci Rep"},{"key":"pone.0357577.ref011","article-title":"Glucagon-like peptide 1 receptor agonists and cancer risk: the good, the bad and the unknown","author":"E Mannucci","year":"2026","journal-title":"Nat Rev Clin Oncol"},{"key":"pone.0357577.ref012","doi-asserted-by":"crossref","first-page":"925377","DOI":"10.3389\/fphar.2022.925377","article-title":"GLP-1 receptor agonist-associated tumor adverse events: a real-world study from 2004 to 2021 based on FAERS","volume":"13","author":"Z Yang","year":"2022","journal-title":"Front Pharmacol"},{"issue":"5","key":"pone.0357577.ref013","article-title":"Significant elevation of serum CA19-9 and CA242 levels induced by dulaglutide","volume":"17","author":"X Shi","year":"2024","journal-title":"BMJ Case Rep"},{"issue":"2","key":"pone.0357577.ref014","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.taap.2014.01.021","article-title":"High fat diet and GLP-1 drugs induce pancreatic injury in mice","volume":"276","author":"R Rouse","year":"2014","journal-title":"Toxicol Appl Pharmacol"},{"key":"pone.0357577.ref015","doi-asserted-by":"crossref","first-page":"963689720927392","DOI":"10.1177\/0963689720927392","article-title":"Long-term liraglutide administration induces pancreas neogenesis in adult T2DM mice","volume":"29","author":"H Deng","year":"2020","journal-title":"Cell Transplant"},{"issue":"5","key":"pone.0357577.ref016","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.2337\/db11-1109","article-title":"Chronic GLP-1 receptor activation by exendin-4 induces expansion of pancreatic duct glands in rats and accelerates formation of dysplastic lesions and chronic pancreatitis in the Kras(G12D) mouse model","volume":"61","author":"B Gier","year":"2012","journal-title":"Diabetes"},{"issue":"6","key":"pone.0357577.ref017","doi-asserted-by":"crossref","DOI":"10.1152\/ajpendo.00479.2010","article-title":"Exenatide does not evoke pancreatitis and attenuates chemically induced pancreatitis in normal and diabetic rodents","volume":"299","author":"K Tatarkiewicz","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"5","key":"pone.0357577.ref018","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.2337\/db11-0936","article-title":"The human GLP-1 analog liraglutide and the pancreas: evidence for the absence of structural pancreatic changes in three species","volume":"61","author":"NCB Nyborg","year":"2012","journal-title":"Diabetes"},{"issue":"7","key":"pone.0357577.ref019","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1177\/0192623315588999","article-title":"Effects of the GLP-1 receptor agonist dulaglutide on the structure of the exocrine pancreas of cynomolgus monkeys","volume":"43","author":"JL Vahle","year":"2015","journal-title":"Toxicol Pathol"},{"issue":"2","key":"pone.0357577.ref020","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"PA Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"pone.0357577.ref021","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: Building an international community of software platform partners","volume":"95","author":"PA Harris","year":"2019","journal-title":"J Biomed Inform"},{"issue":"2","key":"pone.0357577.ref022","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"F Faul","year":"2007","journal-title":"Behav Res Methods"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0357577","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:38:14Z","timestamp":1788975494000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0357577"}},"subtitle":[],"editor":[{"given":"Giovanni","family":"Di Pasquale","sequence":"first","affiliation":[{"name":"National Institutes of Health","place":["UNITED STATES OF AMERICA"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":22,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0357577","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]}}}